A new study reveals that neutrophils, the body's most common white blood cells, act as hidden factories for C4A, the single strongest common genetic risk protein linked to schizophrenia. This discovery connects the immune system directly to the brain disorder and suggests new avenues for diagnosis and treatment.
The Research
Stanford Medicine investigators, led by Dr. Agnes Kalinowski and Dr. Alexander Urban, published findings on May 11 in the Proceedings of the National Academy of Sciences. They used advanced genetic expression tracking to show that neutrophils are actively manufacturing C4A, a complement protein previously thought to be produced mainly in the liver. C4A is known to drive excessive synaptic pruning in the brain—a process that trims away neural connections. In schizophrenia, this pruning goes too far, eliminating roughly 30% of synapses in the cerebral cortex and thinning brain regions critical for higher cognition.
The team discovered that people with schizophrenia have neutrophils that produce an aggressive surge of C4A. Paradoxically, these neutrophils hold onto less C4A, while high levels of its activated form, C4-ana, appear in the blood plasma. This suggests the protein is rapidly consumed and activated somewhere in the body, likely contributing to brain pathology. The number of C4A gene copies a person carries is the strongest common genetic risk factor for schizophrenia, directly dictating C4A levels in the bloodstream.
Interestingly, patients with schizophrenia often have elevated neutrophil counts, and the most effective medication, clozapine, works by depleting circulating neutrophils. This hints that neutrophils are primary drivers of the disease, not a side effect.
Why It Matters
For decades, schizophrenia has been viewed as a brain-specific disorder, with treatments needing to cross the blood-brain barrier. This study flips that idea: if peripheral immune cells are fueling the disease, clinicians could potentially block schizophrenia progression using drugs in the bloodstream, bypassing the complex challenge of targeting the brain directly. It also opens the possibility of diagnosing schizophrenia through a simple blood test measuring C4A or neutrophil activity.
What You Can Do
While this research is early, it highlights how your immune system affects your brain. Supporting general health—through sleep, exercise, and stress management—may help regulate immune function. Stay informed as science uncovers how peripheral factors influence cognition.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
